.FDA rejects psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Accept MDMA Therapy, Finding Additional Study The Nyc TimesFDA Refuses Ecstasy-Based Medicine The Stock market JournalFDA refuses to authorize novel MDMA treatment to handle post-traumatic stress disorder, with request for additional hearing information CNNFDA refuses initially psychedelic to deal with post-traumatic stress disorder, requiring additional research The Washington Blog post.